Cancer News and Research

Latest Cancer News and Research

POZEN announces submission of NDA for marketing approval of PA32540/PA8140

POZEN announces submission of NDA for marketing approval of PA32540/PA8140

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

First Edition: March 26, 2013

First Edition: March 26, 2013

Novel molecular mechanism can prevent aging and cancer progression, say researchers

Novel molecular mechanism can prevent aging and cancer progression, say researchers

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Non-invasive imaging technique for detecting cancer presented at BioPIC 2013

Non-invasive imaging technique for detecting cancer presented at BioPIC 2013

Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

Biological scientists lead major research project that aims to make drugs more effective

Biological scientists lead major research project that aims to make drugs more effective

Cancer patients to get benefit from Elekta's Versa HD system at Hôpital Riviera's radiotherapy clinic

Cancer patients to get benefit from Elekta's Versa HD system at Hôpital Riviera's radiotherapy clinic

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

New analysis reveals online nutritional guidelines for cancer patients appear to be inconsistent

New analysis reveals online nutritional guidelines for cancer patients appear to be inconsistent

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

Research paper highlights implementation of infectious disease curriculum in Boston Public Schools

Academic medical centers launch ASD sub-registry within ResearchMatch

Academic medical centers launch ASD sub-registry within ResearchMatch

New research may shed light on alcohol addiction vulnerability in some people

New research may shed light on alcohol addiction vulnerability in some people

Three Ludwig scientists named as Fellows in inaugural class of AACR Academy

Three Ludwig scientists named as Fellows in inaugural class of AACR Academy

CHOP researchers moving closer to personalized medicine for children with cancer

CHOP researchers moving closer to personalized medicine for children with cancer

Researchers find HPV vaccination disparities among low-income females

Researchers find HPV vaccination disparities among low-income females

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.